HOME >> BIOLOGY >> NEWS
Flexible electronics could find applications as sensors, artificial muscles

Flexible electronic structures with the potential to bend, expand and manipulate electronic devices are being developed by researchers at the U.S. Department of Energy's Argonne National Laboratory and the University of Illinois at Urbana-Champaign. These flexible structures could find useful applications as sensors and as electronic devices that can be integrated into artificial muscles or biological tissues.

In addition to a biomedical impact, flexible electronics are important for energy technology as flexible and accurate sensors for hydrogen.

These structures were developed from a concept created by Argonne scientist Yugang Sun and a team of researchers at the University of Illinois led by John A. Rogers. The concept focuses on forming single-crystalline semiconductor nanoribbons in stretchable geometrical configurations with emphasis on the materials and surface chemistries used in their fabrication and the mechanics of their response to applied strains.

"Flexible electronics are typically characterized by conducting plastic-based liquids that can be printed onto thin, bendable surfaces," Sun said. "The objective of our work was to generate a concept along with subsequent technology that would allow for electronic wires and circuits to stretch like rubber bands and accordions leading to sensor-embedded covers for aircraft and robots, and even prosthetic skin for humans.

"We are presently developing stretchable electronics and sensors for smart surgical gloves and hemispherical electronic eye imagers," he added.

The team of researchers has been successful in fabricating thin ribbons of silicon and designing them to bend, stretch and compress like an accordion without losing their ability to function. The detailed results of these findings were published in the Journal of Materials Chemistry paper, " Structural forms of single crystal semiconductor nanoribbons for high-performance stretchable electronics," whi
'"/>

Contact: Sylvia Carson
scarson@anl.gov
630-252-5510
DOE/Argonne National Laboratory
2-Apr-2007


Page: 1 2

Related biology news :

1. Flexible genes allow ants to change destiny
2. Deflecting damage: Flexible electronics aid brain injury research
3. Juiced-up battery fueled by sugar could power small portable electronics
4. Solitons could power molecular electronics, artificial muscles
5. New U. of Colorado polymer has applications for dentistry, electronics, automobiles
6. Successful test of single molecule switch opens the door to biomolecular electronics
7. MIT: Recycling of scrapped electronics studied
8. Newly created cancer stem cells could aid breast cancer research
9. New system of wastewater treatment could reduce the size of treatment plants by half
10. Discovery of new protein could provide new understanding of male fertility
11. Einstein researchers prototype vaccine could provide improved protection against tuberculosis

Post Your Comments:
(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: